Breshly News

Argon AI has introduced it secured $5.5 million in seed funding. 

Crosslink Capital and Wireframe Ventures co-led the spherical, with participation from Y Combinator, Pioneer Fund and different buyers.

WHAT IT DOES 

Argon AI affords a platform aimed toward serving to life sciences corporations automate data-intensive workflows. Its AI assistants assist with repetitive, handbook and rote duties throughout scientific and business work. 

The AI-enabled platform additionally unifies varied codecs of trade information, together with structured tables, PDFs, slide decks and pictures, throughout completely different information sources akin to medical literature, firm info and convention proceedings.

The corporate will use the funds for product enhancements, crew improvement and buyer enlargement.

“Each business or scientific technique choice is constructed on high of fragmented, outdated or hard-to-access info,” Samy Danesh, CEO and cofounder of Argon AI, mentioned in a press release.

“We’re constructing Argon to make information as accessible and actionable as your inbox and to free life sciences groups to concentrate on bringing new remedies to sufferers.”

MARKET SNAPSHOT 

Different corporations within the information workflow area embody Plenful, a workflow-automation platform for pharmacy and healthcare operations, which in 2024 secured $17 million in Sequence A funding lower than a 12 months after launching with $9 million in funding. 

Plenful affords pharmacy technicians a no-code, AI-enabled automation instrument for handbook and administrative workflows, together with assist with doc information entry for pharmacy income cycle, referral orders, auditing and financial savings identification. 

The corporate used the funds to scale its advertising and marketing, gross sales and product improvement efforts.

That very same 12 months, SamaCare, a workflow platform for suppliers providing specialty treatment, introduced it secured $17 million in an oversubscribed Sequence B funding spherical.

The corporate affords a cloud-based workflow automation platform to help suppliers in acquiring prior authorization for specialty drug drugs, verifying enrollment and checking advantages. 

It additionally works with pharmaceutical corporations to offer information analytics to assist enhance entry to their therapies. 

The corporate used the funds to broaden its Script-to-Remedy Working System, which is able to leverage AI for administrative duties, create a post-prescription workflow, gather information insights and improve collaboration between suppliers’ workplaces.